Weight Loss News and Research

Latest Weight Loss News and Research

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

Researchers at the University of Hong Kong found that Clofazimine, a lipophilic antimicrobial riminophenazine dye used in combination with agents like rifampicin and dapsone to treat leprosy, inhibits coronaviruses, including the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19 disease.

21 Mar 2021

Weight loss induced by diet and bariatric surgery has different impact on mitochondria in fat tissue

Dieting impairs the energy-producing machinery of fat tissue, potentially resulting in weight regain. In contrast, as indicated by a recently completed European study coordinated by the University of Helsinki, weight loss surgery gives a boost to mitochondria, improving the gene expression of these cellular engines.

18 Mar 2021

Rumination syndrome often confused with other gastrointestinal conditions

Patients who regurgitate regularly but without any known cause may have a condition called rumination. Unfortunately, rumination is often confused with other gastrointestinal conditions, which means many patients may not be getting prompt treatment.

18 Mar 2021

Study: One in six men with advanced prostate cancer experiences reduced sense of smell and taste

One in six men being treated for advanced prostate cancer experiences a reduced sense of smell and taste, a symptom that could cause increased anxiety among patients because it is also a side effect of COVID-19, according to Tulane researchers.

16 Mar 2021

Women who are fit and healthy tend to burn more fat when they exercise

Females who are fit and healthy tend to burn more fat when they exercise than men, according to new research from a team of sports nutritionists.

16 Mar 2021

Lithium chloride can alleviate radiation-induced oral mucositis and taste dysfunction

Oral mucositis and taste dysfunction (dysgeusia) occurs in nearly all patients receiving head and neck radiotherapy and tremendously affects the quality of life and treatment outcome.

11 Mar 2021

Lifestyle intervention has cardiovascular benefit for many diabetic patients, but not all

For people who are overweight or obese and have type 2 diabetes, the first line of treatment is usually lifestyle intervention, including weight loss and increased physical activity.

11 Mar 2021

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.

10 Mar 2021

Women with gestational diabetes lack perceived risk of developing type 2 diabetes

While it's an unfair reality that women who develop gestational diabetes are ten times more likely to develop type 2 diabetes later in life, only a third of these women realize that they're at high risk, according to new research by the University of South Australia.

9 Mar 2021

Researchers examine susceptibility of raccoons and striped skunks to SARS-CoV-2 infection

Researchers from the University of Georgia, USA, have found some members of the superfamily Musteloidea – the group that includes badgers and weasels – appear to not only have no effects of the virus, but do little in spreading it.

9 Mar 2021

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

The currently developed vaccines against SARS-CoV-2 include the RBD in their immunogen. With a similar objective, a new study developed an RBD protein-based vaccine candidate against the SARS-CoV-2, using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. The study is published recently in the journal mBio (by the American Society of Microbiology).

8 Mar 2021

Multisystem intervention could potentially prevent or reverse frailty, research shows

Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.

8 Mar 2021

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Researchers have investigated the effectiveness of a bioengineered miniprotein in protecting against SARS-CoV-2 infection in vivo. The researchers evaluated the miniprotein, LCB1, against SARS-CoV-2-mediated lung disease in human ACE2-expressing transgenic mice.

3 Mar 2021

Semaglutide drug also helps diabetic patients lose body weight, shows study

A drug approved for diabetes has now been shown to also help patients with diabetes lose on average 10 percent of their body weight, UT Southwestern reports in a landmark international study.

3 Mar 2021

Study: Semaglutide drug promotes weight loss in patients with type 2 diabetes

Patients with type 2 diabetes that were treated with a weekly injection of the breakthrough drug Semaglutide were able to achieve an average weight loss of nearly 10kg, according to a new study published in The Lancet today.

3 Mar 2021

Some types of fat are more resistant to weight loss, shows study

Scientists have mapped out what happens to fat deposits during intermittent fasting (every second day), with an unexpected discovery that some types of fat are more resistant to weight loss.

3 Mar 2021

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

A new study compares the pathogenicity and infectiousness of one such variant, the VOC 202012/01 (B.1.1.7 lineage) from the United Kingdom, with the globally dominant D614G mutation-carrying strains.

2 Mar 2021

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They demonstrated the high therapeutic efficacy of this homotrimeric Nb, leveraging both intranasal and aerosol delivery.

26 Feb 2021

Study: Majority of COVID-19 hospitalizations attributable to four pre-existing conditions

A modeling study suggests a majority of adult COVID-19 hospitalizations nationwide are attributable to at least one of four pre-existing conditions: obesity, hypertension, diabetes, and heart failure, in that order.

25 Feb 2021

Study shows reliability and robustness of injectable anti-obesity medication

A second study of the injectable anti-obesity medication, semaglutide, has confirmed the large weight losses reported in a study earlier this month, establishing the reliability and robustness of this new drug.

24 Feb 2021

Weight Loss News and Research

Latest Weight Loss News and Research

Clofazimine inhibits coronaviruses including SARS-CoV-2, study finds

Weight loss induced by diet and bariatric surgery has different impact on mitochondria in fat tissue

Rumination syndrome often confused with other gastrointestinal conditions

Study: One in six men with advanced prostate cancer experiences reduced sense of smell and taste

Women who are fit and healthy tend to burn more fat when they exercise

Lithium chloride can alleviate radiation-induced oral mucositis and taste dysfunction

Lifestyle intervention has cardiovascular benefit for many diabetic patients, but not all

New SARS-CoV-2 vaccine candidate produces strong immune response, prevents SARS-CoV-2 infection

Women with gestational diabetes lack perceived risk of developing type 2 diabetes

Researchers examine susceptibility of raccoons and striped skunks to SARS-CoV-2 infection

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Multisystem intervention could potentially prevent or reverse frailty, research shows

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Semaglutide drug also helps diabetic patients lose body weight, shows study

Study: Semaglutide drug promotes weight loss in patients with type 2 diabetes

Some types of fat are more resistant to weight loss, shows study

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Study: Majority of COVID-19 hospitalizations attributable to four pre-existing conditions

Study shows reliability and robustness of injectable anti-obesity medication

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Weight Loss News and Research

Latest Weight Loss News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in